| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/02/2005 | EP1014976B1 Novel substituted imidazole compounds |
| 03/02/2005 | EP0991636B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/02/2005 | EP0919617B1 Anti-human mp52 monoclonal antibody |
| 03/02/2005 | EP0844873B1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 03/02/2005 | EP0824530B1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 03/02/2005 | EP0799311B1 Human chemokine beta-9 |
| 03/02/2005 | EP0797591B1 A novel chemokine expressed in inflamed adenoid, its production and uses |
| 03/02/2005 | CN1589327A Plant enzymes for bioconversion |
| 03/02/2005 | CN1589270A Indole-2-formamide compounds as factor Xa inhibitors |
| 03/02/2005 | CN1589269A Heteroindanes: a new class of potent cannabimimetic ligands |
| 03/02/2005 | CN1589268A Substituted benzopyrans compounds as selective estrogen receptor-beta agonists |
| 03/02/2005 | CN1589262A Cyanoguanidine prodrugs |
| 03/02/2005 | CN1589261A Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/02/2005 | CN1589260A Heterocyclic compounds and methods of use thereof |
| 03/02/2005 | CN1589258A Novel beta -phenyl- alpha -oxysubstituted propionic derivatives: process for their preparation and their use in the preparation of pharmaceutically important compounds |
| 03/02/2005 | CN1589166A Stent coated with a sustained-release drug delivery system and method for use thereof |
| 03/02/2005 | CN1589153A Preventives/remedies for urinary disturbance |
| 03/02/2005 | CN1589149A Reduced toxicity cisplatin formulations and methods for using the same |
| 03/02/2005 | CN1589146A Benzothiazole derivatives as adenosine receptor ligands |
| 03/02/2005 | CN1589145A αv整联蛋白受体拮抗剂 αv integrin receptor antagonists |
| 03/02/2005 | CN1589142A Production of pure stereoisomers of tricyclo[5.2.1.02.6]-dec-9-yl xanthogenate and medicaments therefrom |
| 03/02/2005 | CN1589140A Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 03/02/2005 | CN1589138A Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy |
| 03/02/2005 | CN1589135A Small molecule antagonists of BCL-2 family proteins |
| 03/02/2005 | CN1586595A Wuju tea |
| 03/02/2005 | CN1586571A Health liquid for pet |
| 03/02/2005 | CN1586566A Sweat clearing pill |
| 03/02/2005 | CN1586560A Cordyceps, ginseng, pilose antller, fleece-flower root long life pill |
| 03/02/2005 | CN1586502A Process for preparing compound coemzyme medicine and its compound coemzyme medicine and clinical use |
| 03/02/2005 | CN1586475A Vitamin C oral disintegration tablet and its preparing method |
| 03/02/2005 | CN1191256C Hexahydrofuro[2,3-B] furan-3-yl-N-{3-(1,3-benzodioxo1-5-ylsulfonyl) (isobutyl) Aminol-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor |
| 03/02/2005 | CN1191255C Benzodiazepine derivatives as GABA A receptor modulators |
| 03/02/2005 | CN1191254C Fused pyrrole compounds, pharmaceutical composition containing the same, and the use thereof |
| 03/02/2005 | CN1191243C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 03/02/2005 | CN1191242C Different crystalyzed (-)-6-chloro-4-cyclopropyl ethinyl-4-trifluoride-1, 4-dihydro-2H-3, 1-benzoxazine-2-ketone |
| 03/02/2005 | CN1191241C Pyridazinyl phenyl hydrazones useful against congestive heart failure |
| 03/02/2005 | CN1191236C Substituted 6,6-Hetero-dicycloderivative |
| 03/02/2005 | CN1191087C Antisanility Chinese patent medicine |
| 03/02/2005 | CN1191065C Application of toosendanin as inducer to make differentiation and wither of tumor cells |
| 03/02/2005 | CN1191063C Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 03/02/2005 | CN1191050C Application of two kinds of cationic dye mixture in direct dyeing of keratin fiber |
| 03/01/2005 | US6861529 Cycloalkylpyrrole-3-carboxylic acid amide derivatives and heterocycloalkylpyrrole-3-carboxylic acid amide derivatives that bind with high affinity to the benzodiazepine site of GABA-A (gamma-aminobutyric acid) receptors |
| 03/01/2005 | US6861447 Method for producing a coenzyme Q10/γ-cyclodextrin complex |
| 03/01/2005 | US6861444 Treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances; adrenergic blocking agents |
| 03/01/2005 | US6861438 7-oxo-4,7-dihydro-thieno(3,2-b)pyridine-6-carboxylic acid benzylamide derivatives; herpes viricides |
| 03/01/2005 | US6861437 Substituted imidazo [1,2-a] pyridine derivatives |
| 03/01/2005 | US6861435 3-(amino-imino-methyl)benzyl derivatives with an amide -n-sulfonylamido on the methyl of the benzyl |
| 03/01/2005 | US6861425 Benzimidazole compounds as ORL1-receptor agonists |
| 03/01/2005 | US6861424 A piperazine compound as antithrombotic agent |
| 03/01/2005 | US6861420 N-substituted 1,2,4,5-tetrahydro-1H-benzo[d]azepine compounds |
| 03/01/2005 | US6861418 Modulating protein kinase signal transduction; anticancer agents |
| 03/01/2005 | US6861414 Methods for enhancing graft survival by modulating heme oxygenase activity |
| 03/01/2005 | US6861408 Therapeutic anti-melanoma compounds |
| 03/01/2005 | US6861407 Methods of therapy with thrombin derived peptides |
| 03/01/2005 | US6861406 Use of peptides or small molecules in treatment of disease, in high-throughput screening, in use of metal-binding peptides derived from sequences present in CD74-homology domain of insulin-like growth factor |
| 03/01/2005 | US6861399 Cleaning compositions containing human serine protease T |
| 03/01/2005 | US6861242 Reacting glucosidase and phosphotransferase |
| 03/01/2005 | US6861233 Method of screening for triacyglycerol hydrolase inhibitors |
| 03/01/2005 | US6861228 Modulating Robo: ligand interactions |
| 03/01/2005 | US6861078 Plant extracts with anti-radical type action |
| 03/01/2005 | US6861057 Immunogenic β-amyloid peptide |
| 03/01/2005 | US6861043 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 03/01/2005 | CA2138287C N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 03/01/2005 | CA2133326C Fusion proteins comprising tumor necrosis factor receptor |
| 02/24/2005 | WO2005017151A1 End-deficient mutant of ip3 receptor protein inducing apoptosis |
| 02/24/2005 | WO2005016928A1 Imidazopyridine derivatives |
| 02/24/2005 | WO2005016927A1 Nitrogenous condensed-ring compound and use thereof as hiv integrase inhibitor |
| 02/24/2005 | WO2005016925A1 Azaquinazoline derivatives |
| 02/24/2005 | WO2005016911A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | WO2005016384A1 Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change |
| 02/24/2005 | WO2005016373A1 Osteogenesis promoter |
| 02/24/2005 | WO2005016351A1 Novel use of cannabinoid receptor agonist |
| 02/24/2005 | WO2005016331A1 Therapeutic agent for neuropathic pain containing n-(benzoyl)amino acid derivative as active ingredient |
| 02/24/2005 | WO2004024088A3 Design of chemokine analogs for the treatment of human diseases |
| 02/24/2005 | WO2004010997A8 Sustained-release tablet composition of pramipexole |
| 02/24/2005 | WO2003102206A3 Sgk and nedd used as diagnostic and therapeutic targets |
| 02/24/2005 | WO2003093299A3 Insulin-associated peptides with effects on cerebral health |
| 02/24/2005 | WO2003059273A3 Antibody-avidin fusion proteins as cytotoxic drugs |
| 02/24/2005 | WO2003053921A3 Mutant proteinase inhibitors and uses thereof |
| 02/24/2005 | US20050043544 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 02/24/2005 | US20050043540 such as cis-4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]-N-methyl-N-(3-phenyl-2(E)-propenyl)-benzenemethanamine; |
| 02/24/2005 | US20050043536 Sulfonamides |
| 02/24/2005 | US20050043519 Generating immunoglobulin specific to novel antigen receptor (NAR) for use in innunodiagnostic and immunotherapy |
| 02/24/2005 | US20050043516 TACI antibodies and uses thereof |
| 02/24/2005 | US20050043410 Using an epinephrine type compound; controlling neovascularization |
| 02/24/2005 | US20050043409 Combinations comprising a selective cyclooxygenase-2 inhibitor |
| 02/24/2005 | US20050043399 Dimeric compounds and their use as anti-viral agents |
| 02/24/2005 | US20050043398 such as 2-ethoxycarbonyl-7-hydroxychromone, for the care, preservation or improvement of the general state of the skin or hair |
| 02/24/2005 | US20050043388 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome |
| 02/24/2005 | US20050043387 Tricyclic indole compounds having an affinity against serotonin receptors |
| 02/24/2005 | US20050043386 2-amino-2-(ethyl or methyl)-4-{5-substituted pyrrol-2-yl}butan-1-ols, phosphates and phosphonates; antiarthritic agents; psoriasis; immunosuppressants |
| 02/24/2005 | US20050043383 Combined agents for treatment of glaucoma |
| 02/24/2005 | US20050043375 Solid preparation containing single crystal form |
| 02/24/2005 | US20050043373 Tyrosine phosphatase inhibitor; antidiabetic agents; insulin resistance; obesity |
| 02/24/2005 | US20050043369 Bactericidal antimicrobial methods and compositions for use in treating gram positive infections |
| 02/24/2005 | US20050043356 Polymorphic form of rimonabant method for preparing it and pharmaceutical compositions containing it |
| 02/24/2005 | US20050043352 human YAK family of serine/threonine protein kinases (hyak); use treating diseases of the hematopoietic systems, including anemias, polycythemia, myelodysplastic syndrome, myelosuppression, cytopenia, male contraceptives; 2-(3-Chloro-phenylamino)-7-methoxy-quinoline-3-carboxylic acid for example |
| 02/24/2005 | US20050043350 Administering heterocyclic ether such as 5-chloro-7-hydroxy-3-(4-hydroxyphenylz)-4-oxo-1-benzopyran for prophylaxis of Alzheimer's disease, osteoporosis, cardiovascular disorders, psychological disorders, antiarthritic agents,anxiolytic agents |
| 02/24/2005 | US20050043349 1-Alkyl-1-azoniabicyclo' 2.2.!octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 02/24/2005 | US20050043344 Such as 3-(3,5-ditert-butylphenyl)-4-{3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]-1,2,4-oxadiazol-5-yl}butanoic acid; for treatment of tumor metastasis, angiogenesis, osteoporosis, arthritis, retinopathy, smooth muscle cell migration, restenosis, and atheroscelorosis |